PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
批准号:
10674471
负责人:
HOWARD BAILEY
金额:
$29.66万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2023-03-31
关键词:
Atypical Endometrial HyperplasiasAtypical hyperplasiaComplexContractorDiagnosisEndometrialEndometrial CarcinomaEndometrial HyperplasiaEndometrial Intraepithelial NeoplasiaExemestaneIntraepithelial NeoplasiaMeasuresOperative Surgical ProceduresPilot ProjectsPostmenopauseS-Phase FractionTissuesWomancancer cell
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
-
批准号:10425188
-
项目类别:
-
资助金额:$70.73万
-
财政年份:2021
-
负责人:HOWARD BAILEY
-
依托单位:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
-
批准号:10683047
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2021
-
负责人:HOWARD BAILEY
-
依托单位:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
-
批准号:10045662
-
项目类别:
-
资助金额:$82.22万
-
财政年份:2019
-
负责人:HOWARD BAILEY
-
依托单位:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
-
批准号:10020284
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2017
-
负责人:HOWARD BAILEY
-
依托单位:
IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
-
批准号:9575740
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2017
-
负责人:HOWARD BAILEY
-
依托单位:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
-
批准号:10222480
-
项目类别:
-
资助金额:$10.72万
-
财政年份:2017
-
负责人:HOWARD BAILEY
-
依托单位:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
-
批准号:10458433
-
项目类别:
-
资助金额:$10.74万
-
财政年份:2017
-
负责人:HOWARD BAILEY
-
依托单位:
IGF::OT::IGF - CORE INFRASTRUCTURE SUPPORT
-
批准号:9553428
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2017
-
负责人:HOWARD BAILEY
-
依托单位:
IGF::OT::IGF PHASE IB 9CUAB30 IN EARLY STAGE BREAST CANCER TO EVALUATE BIOLOGIC EFFECT
-
批准号:9369074
-
项目类别:
-
资助金额:$69.23万
-
财政年份:2016
-
负责人:HOWARD BAILEY
-
依托单位:
PHASE IB 9CUAB30 IN EARLY STAGE BREAST CANCER TO EVALUATE BIOLOGIC EFFECT
-
批准号:10249044
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2016
-
负责人:HOWARD BAILEY
-
依托单位:
Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity of Oropharynx Prior to Definitive Treatment
-
批准号:9369071
-
项目类别:
-
资助金额:$55.46万
-
财政年份:2016
-
负责人:HOWARD BAILEY
-
依托单位:
IGF::OT::IGF R&D-A PHASE I TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A DNA PLASMID BASED VACCINE (WOKVAC) ENCODING EPITOPES DERIVED FROM THREE BREAST CANCER ANTIGENS (IGFBP-2, HER2, AND IGF-IR) IN PAT
-
批准号:9162566
-
项目类别:
-
资助金额:$72.75万
-
财政年份:2015
-
负责人:HOWARD BAILEY
-
依托单位:
IGF::OT::IGF - CORE INFRASTRUCTURE SUPPORT
-
批准号:9162557
-
项目类别:
-
资助金额:$80.69万
-
财政年份:2015
-
负责人:HOWARD BAILEY
-
依托单位:
A PHASE I TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A DNA PLASMID BASED VACCINE (WOKVAC) ENCODING EPITOPES DERIVED FROM THREE BREAST CANCER ANTIGENS (IGFBP-2, HER2, AND IGF-IR) IN PAT
-
批准号:9552662
-
项目类别:
-
资助金额:$25.16万
-
财政年份:2015
-
负责人:HOWARD BAILEY
-
依托单位:
A PHASE I TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A DNA PLASMID BASED VACCINE (WOKVAC) ENCODING EPITOPES DERIVED FROM THREE BREAST CANCER ANTIGENS (IGFBP-2, HER2, AND IGF-IR) IN PAT
-
批准号:9275893
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2015
-
负责人:HOWARD BAILEY
-
依托单位:
CORE INFRASTRUCTURE SUPPORT
-
批准号:8948569
-
项目类别:
-
资助金额:$70.92万
-
财政年份:2014
-
负责人:HOWARD BAILEY
-
依托单位:
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
-
批准号:7543351
-
项目类别:
-
资助金额:$105.81万
-
财政年份:2003
-
负责人:HOWARD BAILEY
-
依托单位:--
海外基金